Bingcheng Liu Selected Research

CBFbeta-MYH11 fusion protein

10/2018

Distinct genetic alteration profiles of acute myeloid leukemia between Caucasian and Eastern Asian population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bingcheng Liu Research Topics

Disease

8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2022 - 09/2002
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 10/2011
7	Leukemia 09/2021 - 11/2014
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 10/2014
6	Philadelphia Chromosome 01/2021 - 11/2014
3	Alopecia (Baldness) 03/2021 - 01/2020
2	Neutropenia 01/2021 - 01/2017
2	Blast Crisis (Blast Phase) 01/2021 - 09/2002
2	Cytokine Release Syndrome 10/2020 - 05/2020
1	Reperfusion Injury 03/2021
1	Pruritus (Itching) 03/2021
1	Folliculitis (Sycosis) 03/2021
1	Pain (Aches) 01/2021
1	Edema (Dropsy) 01/2021
1	Exanthema (Rash) 01/2021
1	Anemia 01/2021
1	Hypophosphatemia 01/2021
1	Diarrhea 01/2021
1	AIDS-Related Complex (ARC) 08/2020
1	Skin Neoplasms (Skin Cancer) 05/2020
1	Lymphoma (Lymphomas) 05/2020
1	Brain Diseases (Brain Disorder) 05/2020
1	Candidemia 01/2020
1	Tissue Adhesions 01/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Infections 01/2017
1	Acute Promyelocytic Leukemia 03/2015
1	Mycoses (Diseases, Fungus) 01/2015
1	Chromosome Aberrations (Chromosome Abnormalities) 12/2014
1	Pulmonary Arterial Hypertension 07/2014
1	Dyspnea (Shortness of Breath) 07/2014

Drug/Important Bio-Agent (IBA)

5	Imatinib Mesylate (Gleevec)FDA Link 09/2021 - 07/2014
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 12/2014
3	Dasatinib (BMS 354825)FDA Link 01/2021 - 07/2014
3	Chimeric Antigen ReceptorsIBA 10/2020 - 01/2020
2	venetoclaxIBA 01/2022 - 09/2021
1	Tyrosine Kinase InhibitorsIBA 02/2022
1	COVID-19 VaccinesIBA 01/2022
1	alanyl-leucyl-alanyl-leucine (ALAL)IBA 09/2021
1	Azacitidine (5 Azacytidine)FDA Link 09/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	flumatinibIBA 01/2021
1	Janus KinasesIBA 10/2020
1	CytokinesIBA 10/2020
1	ruxolitinibIBA 10/2020
1	SteroidsIBA 10/2020
1	Therapeutic UsesIBA 01/2020
1	Antifungal AgentsIBA 01/2020
1	HydrogelsIBA 01/2020
1	nilotinib FDA Link 03/2019
1	Core Binding Factors (Core-Binding Factor)IBA 10/2018
1	CBFbeta-MYH11 fusion proteinIBA 10/2018
1	Cytokine Receptors (Cytokine Receptor)IBA 04/2018
1	Co-Repressor ProteinsIBA 04/2018
1	Cyclin-Dependent Kinase Inhibitor p16IBA 04/2018
1	GelsIBA 01/2018
1	HLA-DR Antigens (HLA-DR)IBA 01/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2016
1	Mitoxantrone (Novantrone)FDA LinkGeneric 02/2016
1	Pharmaceutical PreparationsIBA 08/2015
1	HomoharringtonineIBA 03/2015
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2015
1	Caspofungin (Cancidas)FDA Link 01/2015
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2011
1	Busulfan (Busulfex)FDA Link 09/2002
1	Hydroxyurea (Hydrea)FDA LinkGeneric 09/2002
1	N-methylisoindigotinIBA 09/2002
1	indirubinIBA 09/2002

Therapy/Procedure

10	Therapeutics 09/2021 - 11/2014
6	Drug Therapy (Chemotherapy) 09/2021 - 10/2014
2	Transplantation 03/2021 - 08/2020
2	Consolidation Chemotherapy 01/2017 - 03/2015
1	Hyperbaric Oxygenation 03/2021
1	Surgical Instruments (Clip) 08/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 05/2020
1	Ligation 04/2018
1	Sutures (Suture) 01/2018
1	Induction Chemotherapy 01/2017
1	Hematopoietic Stem Cell Transplantation 12/2014